abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding abrdn Life Sciences Investors changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 76 | 1 | 83 | +8 |
| Shares | 9.17M | 138 | 9.15M | −24.9K (−0.3%) |
| Value | $117.5M | $1.77K | $141.7M | +$24.1M (+20.5%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held abrdn Life Sciences Investors at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Thomas J. Herzfeld Advisors, Inc. | 116,937 | $1.81M | 0.62% |
| Pensionmark Financial Group, LLC | 92,866 | $1.44M | 0.03% |
| Janney Montgomery Scott LLC | 82,345 | $1.28M | 0.00% |
| Marex Group plc | 56,967 | $883.6K | 0.01% |
| PMG Family Office LLC | 22,636 | $351.1K | 0.39% |
| Balyasny Asset Management LLC | 18,340 | $284.5K | 0.00% |
| Jane Street Group, LLC | 13,971 | $216.7K | 0.00% |
| Cornerstone Advisors, LLC | 11,300 | $175.3K | 0.01% |
| Highline Wealth Partners LLC | 1,000 | $15.5K | 0.00% |
| Advisory Services Network, LLC | 852 | $13.2K | 0.00% |
| Rockefeller Capital Management L.P. | 642 | $9.96K | 0.00% |
| Jones Financial Companies LLLP | 125 | $1.85K | 0.00% |
| Northwestern Mutual Wealth Management Co | 35 | $543 | 0.00% |
| Quent Capital, LLC | 1 | $16 | 0.00% |
Sold out (6)
Institutions that held abrdn Life Sciences Investors at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Readystate Asset Management LP | 28,431 | $364.2K |
| Clough Capital Partners L P | 24,850 | $318.0K |
| Geneos Wealth Management Inc. | 2,293 | $29.4K |
| Nexus Investment Management ULC | 1,489 | $19.1K |
| Bryn Mawr Trust Co | 1,200 | $15.4K |
| Garde Capital, Inc. | 100 | $1.28K |
Not filed for Q3 2025 yet (1)
Institutions that held abrdn Life Sciences Investors at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Atlas Capital Advisors LLC | 138 | $1.77K |